000805984 000__ 03756cam\a2200517Mi\4500
000805984 001__ 805984
000805984 005__ 20230306143816.0
000805984 006__ m\\\\\o\\d\\\\\\\\
000805984 007__ cr\un\nnnunnun
000805984 008__ 171027s2017\\\\gw\a\\\\ob\\\\000\0\eng\d
000805984 019__ $$a1008962868$$a1008986666$$a1009283692$$a1013509221
000805984 020__ $$a9783319653198
000805984 020__ $$a3319653199
000805984 020__ $$z9783319653181
000805984 020__ $$z3319653180
000805984 0247_ $$a10.1007/978-3-319-65319-8$$2doi
000805984 035__ $$aSP(OCoLC)on1013916126
000805984 035__ $$aSP(OCoLC)1013916126$$z(OCoLC)1008962868$$z(OCoLC)1008986666$$z(OCoLC)1009283692$$z(OCoLC)1013509221
000805984 040__ $$aUPM$$beng$$epn$$cUPM$$dN$T$$dGW5XE$$dDKU$$dEBLCP$$dYDX$$dOCLCO$$dOCLCQ$$dOCLCF
000805984 049__ $$aISEA
000805984 050_4 $$aQH588.S83
000805984 08204 $$a571.6$$223
000805984 24500 $$aHaploidentical Stem Cell Transplantation :$$ban Emerging Treatment Modality /$$cedited by Taner Demirer.
000805984 264_1 $$aCham :$$bSpringer International Publishing :$$bImprint :$$bHumana Press,$$c2017.
000805984 300__ $$a1 online resource (xv, 199 pages) :$$billustrations.
000805984 336__ $$atext$$btxt$$2rdacontent
000805984 337__ $$acomputer$$bc$$2rdamedia
000805984 338__ $$aonline resource$$bcr$$2rdacarrier
000805984 347__ $$atext file$$bPDF$$2rda
000805984 4901_ $$aStem Cell Biology and Regenerative Medicine,$$x2196-8985
000805984 504__ $$aIncludes bibliographical references.
000805984 5050_ $$a1. General Indications and Logic for Haploidentical SCT -- 2. Donor Selection and Cell Dose in Haploidentical SCT -- 3. Graft Failure and Rejection in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 5. An Overview of the Prophylaxis and Treatment of GVHD in Haploidentical STC -- 6. Prevention and Treatment of Infectious Complications in Haploidentical SCT -- 7. Graft versus Leukemia (GVL), Graft versus Lymphoma Effect in Haploidentical SCT -- 8. Outcome of Haploidentical SCT in Patients with Acute Leukemia -- 9. Outcome of Haploidentical SCT in Patients with Lymphoma -- 10. Applications of Haploidentical SCT in Patients with Non-malignant Diseases -- 11. Applications of Haploidentical SCT in Pediatric Patients -- 12. Innovative Approaches in Order to Increase the Success of the Haploidentical SCT. 13. Future Perspectives for Haploidentical SCT.
000805984 506__ $$aAccess limited to authorized users.
000805984 520__ $$aThis book discusses the aspects of haploidentical transplants and will shed light on the debates and questions on this burgeoning field and timely topic. Donor selection, graft failure, minimal CD34+ cell requirement, and conditioning regimens used for haploidentical transplants will be written by expert authors dealing with this type of transplants. Approximately one third of the books' chapters cover logic and basic aspects; the remaining two thirds of the book discuss clinical aspects, outcomes, and future perspectives, thus providing a comphrensive discussion of the topic. Haploidentical transplantation is extremely timely, rapidly-changing area and increasing its use will decrease the need for time-consuming, expensive, unrelated donor search. Moreover, Haploidentical Stem Cell Transplantation brings a set of clear answers to questions of feasibility, advantages over unrelated transplants, cost effectivity and outcome.
000805984 650_0 $$aLife sciences.
000805984 650_0 $$aCancer$$xResearch.
000805984 650_0 $$aHematology.
000805984 650_0 $$aOncology.
000805984 650_0 $$aStem cells.
000805984 7001_ $$aDemirer, Taner,$$eeditor.
000805984 77608 $$iPrint version:$$z9783319653181
000805984 830_0 $$aStem cell biology and regenerative medicine.
000805984 852__ $$bebk
000805984 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-65319-8$$zOnline Access$$91397441.1
000805984 909CO $$ooai:library.usi.edu:805984$$pGLOBAL_SET
000805984 980__ $$aEBOOK
000805984 980__ $$aBIB
000805984 982__ $$aEbook
000805984 983__ $$aOnline
000805984 994__ $$a92$$bISE